143 related articles for article (PubMed ID: 1571912)
1. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
Komaki R; Wadler S; Peters T; Byhardt RW; Order S; Gallagher MJ; Herskovic A; Pederson J
Cancer; 1992 Jun; 69(11):2807-12. PubMed ID: 1571912
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas.
Komaki R; Hansen R; Cox JD; Wilson JF
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1447-52. PubMed ID: 3198442
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.
Rich T; Harris J; Abrams R; Erickson B; Doherty M; Paradelo J; Small W; Safran H; Wanebo HJ
Am J Clin Oncol; 2004 Feb; 27(1):51-6. PubMed ID: 14758134
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
[TBL] [Abstract][Full Text] [Related]
5. Treatment of probable subclinical liver metastases and gross pancreatic carcinoma with hepatic artery 5-fluorouracil infusion and radiation therapy.
Wiley AL; Wirtanen GW; Mehta MP; Ramirez G; Shahabi S
Acta Oncol; 1988; 27(4):377-81. PubMed ID: 3202995
[TBL] [Abstract][Full Text] [Related]
6. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer.
Penberthy DR; Rich TA; Shelton CH; Adams R; Minasi JS; Jones RS
Ann Oncol; 2001 May; 12(5):681-4. PubMed ID: 11432628
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation.
Evans DB; Abbruzzese JL; Cleary KR; Buchholz DJ; Fenoglio CJ; Collier C; Rich TA
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):913-8. PubMed ID: 7591902
[TBL] [Abstract][Full Text] [Related]
9. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
Carducci MA; Abrams RA; Yeo CJ; Hruban RH; Zahurak ML; Cameron JL; Grochow LB
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):143-50. PubMed ID: 8641911
[TBL] [Abstract][Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer: treatment with neutron irradiation alone and with chemotherapy.
Cohen L; Hendrickson FR; Lennox AJ; Kroc TK; Hatcher MA; Bennett BR
Radiology; 1996 Sep; 200(3):627-30. PubMed ID: 8756907
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.
Hoffman JP; Lipsitz S; Pisansky T; Weese JL; Solin L; Benson AB
J Clin Oncol; 1998 Jan; 16(1):317-23. PubMed ID: 9440759
[TBL] [Abstract][Full Text] [Related]
13. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Coia LR; Engstrom PF; Paul A
J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
[TBL] [Abstract][Full Text] [Related]
14. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
16. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Picozzi VJ; Kozarek RA; Traverso LW
Am J Surg; 2003 May; 185(5):476-80. PubMed ID: 12727570
[TBL] [Abstract][Full Text] [Related]
17. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
[TBL] [Abstract][Full Text] [Related]
19. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.
Mohiuddin M; Cantor RJ; Biermann W; Weiss SM; Barbot D; Rosato FE
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):79-84. PubMed ID: 3121546
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
